Literature DB >> 12412765

Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.

A K Cheung1, C J Parker, L Wilcox.   

Abstract

Autologous porcine plasma that has been incubated with cuprophan haemodialysis membranes causes pulmonary hypertension and peripheral leucopenia following reinfusion into swine. These effects appear to be mediated by biologically active fragments of C3 and C5 that are generated as a consequence of ex vivo activation of complement. Putatively, C5a induces the leucopenia; however, the specific contributions of products of C3 and C5 activation to the pulmonary vasoconstriction have not been elucidated. In the present study, the effects of in vivo infusion of two different types of cobra venom factor (CVF) on peripheral leucocyte count and pulmonary artery pressure in the swine are reported. The CVF from Naja n. naja (CVF(TN)) was shown to activate both porcine C3 and C5, whereas the CVF from Naja h. haje (CVF(NH)) activated only C3. Both types of CVF produced pulmonary hypertension. Significant peripheral leucopenia, however, was observed only with CVF(TN). These results suggest that activation products of C3 contribute to the pulmonary hypertension but not to the peripheral leucopenia observed during haemodialysis using dialysis membranes that activate complement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 12412765      PMCID: PMC1534660     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor.

Authors:  T Kabakçi; W F Rosse; G L Logue
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

4.  Release of histamine from rat mast cells by the complement peptides C3a and C5a.

Authors:  A R Johnson; T E Hugli; H J Müller-Eberhard
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

5.  Regionally variable pulmonary artery responses to C3a.

Authors:  R E Crowell; W P Reed; D Van Epps; T Anaya; D E Chenoweth; J Leach; T W Chick
Journal:  Am J Physiol       Date:  1988-11

6.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.

Authors:  P J Lachmann; L Halbwachs
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

7.  Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.

Authors:  I H Lepow; K Willms-Kretschmer; R A Patrick; F S Rosen
Journal:  Am J Pathol       Date:  1970-10       Impact factor: 4.307

8.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

9.  Formation and function of a complex of the C3 proactivator with a protein from cobra venom.

Authors:  N R Cooper
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  2 in total

1.  Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice.

Authors:  Eileen M Bauer; Han Zheng; Suzy Comhair; Serpil Erzurum; Timothy R Billiar; Philip M Bauer
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

2.  A proteome signature of umbilical cord serum associated with congenital diaphragmatic hernia.

Authors:  Asuka Tachi; Yoshinori Moriyama; Hiroyuki Tsuda; Rika Miki; Takafumi Ushida; Mayo Miura; Yumiko Ito; Kenji Imai; Tomoko Nakano-Kobayashi; Masahiro Hayakawa; Fumitaka Kikkawa; Tomomi Kotani
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.